Anti-VEGF, 'vascular endothelial growth factor', medication is a treatment that can help stop the progression of wet AMD. This medication Lucentis (Ranibizumab) has to be injected into the eye using a very fine needle under local anaesthetic. This typically results in prevention of further loss of vision, and can also lead to improved vision. The patient will need to be monitored for further leakage of fluid in the eye.

Eylea (Aflibercept) is also an AntiVEGF therapy and works by targeting abnormal retinal blood vessels, reducing or stopping the bleeding and leakage . This typically results in prevention of further loss of vision, and can also lead to improved vision.